The World Health Organization (WHO) today announced the launch of the Strategy to Achieve Global Covid-19 Vaccination by Mid-2022 (the Strategy) to help end what has become a two-track pandemic, in which people in poorer countries remain at risk while those in richer countries with high vaccination rates benefit greatly.
By the end of September, WHO had set a goal of vaccinating 10% of every country, economy, and territory, but 56 countries had failed to do so, the vast majority of which are in Africa and the Middle East.
The new strategy lays out a method for meeting WHO’s goals of vaccinating 40% of the population of every nation by the end of this year and 70% by the middle of 2022.
To meet the global vaccination targets, a three-step approach to vaccination should be used, with all older adults, health workers, and high-risk groups of all ages being vaccinated first in each country, followed by the full adult age group in each country, and finally extended vaccination of adolescents.
Vaccinating 70% of the world’s population would necessitate at least 11 billion vaccine doses. Just over 6 billion doses had been administered worldwide by the end of September. With global vaccine production already nearing 1.5 billion doses per month, there is enough vaccine to meet global vaccination targets if doses are distributed evenly.
Through COVAX, the African Vaccine Acquisition Trust (AVAT), and bilateral contracts, significant funding has already been allocated to buy the majority of the needed vaccine doses for low- and lower-middle-income nations. Additional funding is required to procure leftover vaccination doses for these nations, as well as funding to support in-country delivery.
The Strategy lays out the priority actions that each actor will need to take in order to meet the goals.
WHO, Gavi, UNICEF, and CEPI must continue to work closely with the World Bank, World Trade Organization, International Monetary Fund, Africa CDC, AVAT, and other key partners to monitor progress, identify changes needed to resolve bottlenecks, coordinate information, and priorities actions; co-lead and manage the COVAX Pillar of the ACT-Accelerator; and support the equitable allocation of available vaccines, particularly to low-, lower-middle-income, and Directly support countries in developing and sustaining rapid, effective, high-quality COVID-19 vaccine delivery programmes that can meet global targets; address key research, policy, safety, and regulatory issues that will optimize vaccine impact, such as effective supply, dosing and vaccine schedules, mixing and matching of products, protection against variants, and other issues; and track and report on progress toward the global COVID-19 vaccination goals on a monthly basis.
The primary global immunization partners created a worldwide COVID-19 vaccination strategy through the Access to COVID-19 Tools Accelerator (ACT-A) Vaccines Pillar after the WHO declared novel coronavirus a public health emergency of international concern on 30 January 2020. (COVAX). The prioritized plan and budget for ACT-A can be seen here. The Global Vaccination Strategy for 2022 is meant to complement it.
The global COVID-19 vaccine strategy’s immediate goal is to reduce the number of deaths, severe disease, and total disease burden; lessen the impact on health systems; completely restart socioeconomic activities; and lower the risk of new variations.
The Global COVID-19 Vaccination Strategy for 2022 is based on a technical analysis that created a Conceptual COVID-19 Goal Framework that provides a series of socioeconomic and health goals that might be reached with different levels of vaccination scope and other interventions. The Conceptual Goal Framework is based on WHO’s wider COVID-19 Strategic Preparedness and Response Plan (SPRP), which was first published in 2020 and updated in 2021, and structures technical studies of vaccination requirements to accomplish ever broader health, social, and economic goals. The SPRP’s strategic objectives inform and fit with the Global COVID-19 Vaccine Strategic Vision Goal Framework’s health and socioeconomic components.